PGNY
Progyny, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Buy
+24/100
Last price
25.91
▲ 0.05 (0.19%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
25.76
Prev close
25.86
Day high
26.24
Day low
25.56
Volume
868.32K
Market cap
$1.99B
P/E (TTM)
28.16
52W range
16.10 – 33.07
Day trading desk
Gap from prior close
-0.39%
Prior close 25.86
VWAP
25.92
-0.05% from price
Relative volume
1.04×
Normal
Session range
2.90%
25.50 – 26.24
Position in range
55%
Mid range
ATR (14D)
0.73
2.82% of price
Prior day high
25.92
PDH
Prior day low
25.01
PDL
Bid / ask spread
—
Quote not published
Session volume
1.18M
Avg 1.14M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+4.52%
+2.6%
1M
-0.12%
-1.3%
3M
-15.77%
-20.3%
6M
+50.99%
+32.8%
YTD
+0.90%
-13.4%
1Y
+25.84%
+9.4%
3Y
-23.84%
-106.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PGNY open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+43.55K
Net buying
Buy transactions
11
100.52K shares
Sell transactions
12
56.96K shares
Net transactions
+23
Buys less sells
Sell : buy shares
0.6 : 1
Mixed
Insider-held shares
1.52M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 23, 26 | SWARTZ ALLISON General Counsel |
SELL | 3.90K | $101.87K | Direct |
| Sep 10, 26 | GORDON KEVIN K Director |
SELL | 11.50K | $321.36K | Direct |
| Sep 10, 26 | GORDON KEVIN K Director |
CONVERSION | 22.00K | $286.00K | Direct |
| Jul 14, 26 | CUMMINGS MELISSA B Chief Operating Officer |
SELL | 2.24K | $70.91K | Direct |
| Jun 4, 26 | LIVINGSTON MARK S Chief Financial Officer |
SELL | 2.52K | $64.18K | Direct |
| Jun 4, 26 | SWARTZ ALLISON General Counsel |
SELL | 1.80K | $45.02K | Direct |
| Jun 2, 26 | LIVINGSTON MARK S Chief Financial Officer |
SELL | 279 | $7.31K | Direct |
| Jun 2, 26 | CLAPP GEOFFREY Officer |
SELL | 1.53K | $39.14K | Direct |
| Jun 2, 26 | CLAPP GEOFFREY Officer |
CONVERSION | 12.91K | $269.93K | Direct |
| Jun 1, 26 | SCOTT CHERYL M Director |
SELL | 7.44K | $196.28K | Direct |
| Jun 1, 26 | SCOTT CHERYL M Director |
CONVERSION | 14.67K | $190.67K | Direct |
| May 28, 26 | SWARTZ ALLISON General Counsel |
SELL | 2.40K | $61.05K | Direct |
| May 27, 26 | GORDON KEVIN K Director |
SELL | 5.50K | $137.44K | Direct |
| May 21, 26 | PAYSON NORMAN Director |
STOCK | 5.66K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ANEVSKI PETER |
Chief Executive Officer | 816.83K | Stock Award(Grant) |
CLAPP GEOFFREY |
Officer | 60.65K | Sale |
CUMMINGS MELISSA B |
Chief Operating Officer | 69.93K | Sale |
DEAN LLOYD H |
Director | 26.52K | Stock Award(Grant) |
HOLSTEIN ROGER C |
Director | 28.73K | Stock Award(Grant) |
LIVINGSTON MARK S |
Chief Financial Officer | 74.69K | Sale |
PARK JEFFREY G |
Director | 39.98K | Stock Award(Grant) |
PAYSON NORMAN |
Director | 466.20K | Stock Award(Grant) |
SCHLANGER DAVID J |
Officer and Director | 240.63K | Stock Award(Grant) |
SWARTZ ALLISON |
General Counsel | 75.82K | Sale |
Fundamentals
Market cap$1.99B
Enterprise value$1.78B
Revenue (TTM)$1.31B
Gross profit$322.09M
EBITDA$125.57M
Net income$78.63M
EPS (TTM)$0.92
Free cash flow$196.47M
Total cash$236.92M
Total debt$26.97M
Book value / share$5.90
Shares outstanding76.73M
Float70.23M
Short % of float8.67%
Dividend yield0.00%
Beta (5Y)1.02
Valuation & profitability ratios
Trailing P/E28.16
Forward P/E11.17
PEG ratio—
Price / sales—
Price / book4.39
EV / revenue1.36
EV / EBITDA14.16
Gross margin24.57%
Operating margin11.41%
Profit margin6.00%
Return on equity16.24%
Return on assets10.14%
Debt / equity5.95
Current ratio2.14
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.29B | $1.17B | $1.09B | $786.91M | +10.4% |
| Operating revenue | $1.29B | $1.17B | $1.09B | $786.91M | +10.4% |
| Cost of revenue | $984.18M | $913.86M | $849.80M | $619.59M | +7.7% |
| Gross profit | $304.48M | $253.36M | $238.80M | $167.32M | +20.2% |
| Selling, general & admin | $219.21M | $185.91M | $176.62M | $143.98M | +17.9% |
| Total operating expense | $219.21M | $185.91M | $176.62M | $143.98M | +17.9% |
| Operating income | $85.28M | $67.45M | $62.18M | $23.34M | +26.4% |
| Net interest income | $10.15M | $15.75M | $8.51M | $1.10M | -35.5% |
| Pre-tax income | $95.43M | $83.20M | $70.69M | $24.44M | +14.7% |
| Tax provision | $36.91M | $28.87M | $8.65M | -$5.92M | +27.9% |
| Net income | $58.52M | $54.34M | $62.04M | $30.36M | +7.7% |
| Net income to common | $58.52M | $54.34M | $62.04M | $30.36M | +7.7% |
| Basic EPS | 0.68 | 0.59 | 0.65 | 0.33 | +15.3% |
| Diluted EPS | 0.65 | 0.57 | 0.62 | 0.30 | +14.0% |
| EBIT | $85.28M | $67.45M | $62.18M | $23.34M | +26.4% |
| EBITDA | $90.22M | $70.63M | $64.47M | $24.94M | +27.7% |
| Basic shares | 85.65M | 91.48M | 95.02M | 92.20M | -6.4% |
| Diluted shares | 89.86M | 95.45M | 100.67M | 99.96M | -5.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $112.24M | $162.31M | $97.30M | $120.08M | -30.9% |
| Cash & short-term investments | $310.10M | $227.95M | $371.09M | $189.30M | +36.0% |
| Accounts receivable | $220.29M | $235.32M | $241.87M | $240.07M | -6.4% |
| Total current assets | $551.77M | $472.72M | $640.41M | $433.86M | +16.7% |
| Property, plant & equipment | $54.92M | $29.63M | $27.82M | $15.27M | +85.3% |
| Goodwill & intangibles | $26.19M | $16.84M | $11.88M | $11.98M | +55.6% |
| Total assets | $742.43M | $607.10M | $756.62M | $542.99M | +22.3% |
| Total current liabilities | $202.39M | $168.63M | $185.95M | $159.54M | +20.0% |
| Total debt | $27.73M | $19.27M | $19.39M | $7.71M | +43.9% |
| Total liabilities | $226.39M | $185.04M | $203.19M | $166.02M | +22.3% |
| Retained earnings | $202.83M | $144.31M | $89.97M | $27.93M | +40.6% |
| Shareholder equity | $516.04M | $422.06M | $553.43M | $376.97M | +22.3% |
| Working capital | $349.38M | $304.09M | $454.46M | $274.32M | +14.9% |
| Net tangible assets | $489.85M | $405.23M | $541.55M | $364.99M | +20.9% |
| Shares issued | 99.67M | 98.31M | 96.96M | 93.92M | +1.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $58.52M | $54.34M | $62.04M | $30.36M | +7.7% |
| Depreciation & amortisation | $4.95M | $3.17M | $2.28M | $1.60M | +55.8% |
| Stock-based compensation | $131.87M | $128.13M | $122.61M | $100.75M | +2.9% |
| Change in working capital | $2.80M | -$11.78M | -$17.42M | -$59.49M | +123.8% |
| Operating cash flow | $210.19M | $179.10M | $188.81M | $80.39M | +17.4% |
| Capital expenditure | -$18.41M | -$5.41M | -$3.64M | -$3.24M | -240.6% |
| Investing cash flow | -$159.01M | $195.79M | -$200.53M | -$43.87M | -181.2% |
| Share buybacks | -$81.66M | -$300.28M | $0 | $0 | +72.8% |
| Financing cash flow | -$99.36M | -$309.88M | -$11.07M | -$7.86M | +67.9% |
| Free cash flow | $191.78M | $173.70M | $185.17M | $77.15M | +10.4% |
| End cash position | $114.19M | $162.31M | $97.30M | $120.08M | -29.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $350.51M | $328.50M | $318.40M | $313.35M | $332.87M | +6.7% |
| Operating revenue | $350.51M | $328.50M | $318.40M | $313.35M | $332.87M | +6.7% |
| Cost of revenue | $261.21M | $245.43M | $241.52M | $240.51M | $253.90M | +6.4% |
| Gross profit | $89.30M | $83.07M | $76.88M | $72.83M | $78.97M | +7.5% |
| Selling, general & admin | $49.30M | $47.69M | $61.66M | $51.31M | $54.62M | +3.4% |
| Total operating expense | $49.30M | $47.69M | $61.66M | $51.31M | $54.62M | +3.4% |
| Operating income | $40.00M | $35.38M | $15.22M | $21.53M | $24.36M | +13.1% |
| Net interest income | $1.13M | $1.50M | $2.63M | $2.44M | $2.72M | -24.6% |
| Pre-tax income | $41.14M | $36.88M | $17.85M | $23.96M | $27.08M | +11.5% |
| Tax provision | $13.09M | $12.65M | $5.37M | $10.10M | $9.96M | +3.4% |
| Net income | $28.05M | $24.23M | $12.48M | $13.86M | $17.11M | +15.8% |
| Net income to common | $28.05M | $24.23M | $12.48M | $13.86M | $17.11M | +15.8% |
| Basic EPS | 0.36 | 0.30 | 0.15 | 0.16 | 0.20 | +20.0% |
| Diluted EPS | 0.34 | 0.29 | 0.14 | 0.15 | 0.19 | +17.2% |
| EBIT | $40.00M | $35.38M | $15.22M | $21.53M | $24.36M | +13.1% |
| EBITDA | $41.63M | $36.86M | $16.59M | $22.80M | $25.56M | +12.9% |
| Basic shares | 78.17M | 80.92M | 85.23M | 86.02M | 85.77M | -3.4% |
| Diluted shares | 82.14M | 84.76M | 89.46M | 90.23M | 89.64M | -3.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $152.63M | $131.61M | $112.24M | $133.98M | $132.51M | +16.0% |
| Cash & short-term investments | $236.93M | $225.11M | $310.10M | $345.21M | $305.09M | +5.2% |
| Accounts receivable | $257.48M | $263.61M | $220.29M | $252.50M | $271.85M | -2.3% |
| Total current assets | $513.02M | $501.55M | $551.77M | $622.01M | $594.40M | +2.3% |
| Property, plant & equipment | $65.57M | $59.98M | $54.92M | $50.42M | $46.37M | +9.3% |
| Goodwill & intangibles | $25.60M | $25.85M | $26.19M | $26.39M | $26.61M | -1.0% |
| Total assets | $715.84M | $698.34M | $742.43M | $795.23M | $760.95M | +2.5% |
| Total current liabilities | $240.08M | $235.74M | $202.39M | $210.49M | $220.42M | +1.8% |
| Total debt | $22.50M | $23.25M | $27.73M | $24.73M | $25.50M | -3.3% |
| Total liabilities | $262.58M | $258.99M | $226.39M | $235.22M | $245.93M | +1.4% |
| Retained earnings | $255.11M | $227.06M | $202.83M | $190.34M | $176.48M | +12.4% |
| Shareholder equity | $453.26M | $439.34M | $516.04M | $560.00M | $515.02M | +3.2% |
| Working capital | $272.93M | $265.81M | $349.38M | $411.52M | $373.98M | +2.7% |
| Net tangible assets | $427.66M | $413.49M | $489.85M | $533.61M | $488.42M | +3.4% |
| Shares issued | 77.39M | 100.08M | 99.67M | 99.15M | 98.93M | -22.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $28.05M | $24.23M | $12.48M | $13.86M | $17.11M | +15.8% |
| Depreciation & amortisation | $1.62M | $1.48M | $1.37M | $1.27M | $1.21M | +9.4% |
| Stock-based compensation | $20.48M | $19.72M | $34.80M | $32.17M | $32.38M | +3.8% |
| Change in working capital | -$5.58M | -$5.41M | $8.80M | -$790.00K | $519.00K | -3.1% |
| Operating cash flow | $50.42M | $45.95M | $54.20M | $50.67M | $55.51M | +9.7% |
| Capital expenditure | -$6.22M | -$6.35M | -$5.61M | -$4.68M | -$5.27M | +2.0% |
| Investing cash flow | $3.55M | $96.59M | $8.26M | -$42.74M | -$29.91M | -96.3% |
| Share buybacks | -$30.02M | -$118.61M | -$81.66M | $0 | $0 | +74.7% |
| Financing cash flow | -$32.89M | -$123.11M | -$88.26M | -$5.49M | -$2.33M | +73.3% |
| Free cash flow | $44.21M | $39.60M | $48.59M | $45.99M | $50.24M | +11.6% |
| End cash position | $154.60M | $133.57M | $114.19M | $139.98M | $137.54M | +15.7% |
Options analytics
Put / call volume
0.14
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
20.00
-22.8% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
-18.7%
Calls bid over puts
Call volume
14
Contracts, this expiry
Put volume
2
Contracts, this expiry
Heaviest call OI
20.00
0 contracts
Heaviest put OI
25.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.52 | 0.55 | +6.2% |
| Mar 2026 | 0.44 | 0.50 | +14.7% |
| Dec 2025 | 0.40 | 0.48 | +19.9% |
| Sep 2025 | 0.39 | 0.45 | +15.4% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.51 | 9 | $340.62M | +8.7% |
| Next quarter | 0.53 | 9 | $354.89M | +11.5% |
| Current year | 2.08 | 9 | $1.37B | +6.7% |
| Next year | 2.32 | 9 | $1.51B | +10.0% |
Analyst targets & ownership
Mean target$34.42
High target$40.00
Low target$30.00
Implied upside32.83%
Analyst count12
ConsensusNONE
Strong buy / Buy1 / 9
Hold2
Sell / Strong sell0 / 0
Held by insiders1.98%
Held by institutions110.36%
Institutions holding435
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
25.46
+1.77% from price
SMA 20
26.32
-1.55% from price
SMA 50
27.01
-4.09% from price
SMA 100
27.43
-5.52% from price
SMA 200
24.20
+7.05% from price
EMA 12
25.74
+0.66% from price
EMA 26
26.19
-1.06% from price
EMA 50
26.63
-2.72% from price
RSI (14)
46.9
Neutral
MACD (12,26,9)
-0.45
Hist -0.01
ATR (14)
0.73
2.82% of price
Realised vol 30D
27.6%
Annualised
Bollinger upper
28.24
20, 2σ
Bollinger lower
24.40
20, 2σ
50 / 200 cross
Golden
27.01 vs 24.20
Trend bias
Above 200
+7.05%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.34
Less volatile than market
Correlation to SPY
0.08
Largely independent
Realised vol 30D
27.6%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-42.6%
Peak to trough
Max drawdown 5Y
-79.5%
Peak to trough
ATR 14
0.73
2.82% of price
Beta (reported)
1.02
5Y monthly, from filing
Short interest
Shares short
4.71M
Prior 4.57M
Change vs prior
+3.0%
Shorts adding
% of float
8.67%
Normal
% of shares out
6.14%
Against total outstanding
Days to cover
4.6
Liquid
Float
70.23M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 30, 26 | Wells Fargo | INITIATED | — | Overweight |
| Sep 8, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| Aug 21, 26 | JP Morgan | MAINTAINED | Neutral | Neutral |
| Aug 20, 26 | Wells Fargo | INITIATED | — | Overweight |
| Aug 13, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Aug 12, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Jul 28, 26 | Barclays | DOWNGRADE | Overweight | Equal-Weight |
| Jul 24, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jul 21, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Jul 13, 26 | Keybanc | MAINTAINED | Overweight | Overweight |
| Jun 22, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Jun 2, 26 | B of A Securities | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Periodic Financial Reports
10-Q · 2026-08-07
Corporate Changes & Voting Matters
8-K · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-05-27
Corporate Changes & Voting Matters
8-K · 2026-05-26
Periodic Financial Reports
10-Q · 2026-05-08
Corporate Changes & Voting Matters
8-K · 2026-05-07
Proxy Statements
DEF 14A · 2026-04-10
Proxy Statements
PRE 14A · 2026-03-31
Headlines
3 Profitable Stocks with Warning Signs
StockStory · 13d ago
PGNY vs. CRL: Which Stock Is the Better Value Option?
Zacks · 19d ago
Progyny (PGNY) Stock Looks Fairly Valued Despite Its 57% Five Year Slide
Simply Wall St. · 19d ago
Concentra Group Holdings Parent, Inc. (CON) Hits Fresh High: Is There Still Room to Run?
Zacks · 22d ago
Progyny Insider Sold Shares Worth $321,358, According to a Recent SEC Filing
MT Newswires · 22d ago
Spotting Winners: Progyny (NASDAQ:PGNY) And Health Insurance Providers Stocks In Q2
StockStory · 26d ago
Wall Street Analysts Predict a 25.23% Upside in Progyny (PGNY): Here's What You Should Know
Zacks · 28d ago
Progyny, Inc. to Present at the Wells Fargo Healthcare Conference
GlobeNewswire · 34d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.